Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapphire Bioscience is a premier distributor of life science research products based in Australia, serving the scientific community across Australia and New Zealand. The company provides a vast range of high-quality reagents, including antibodies, proteins, ELISA kits, and small molecules, sourced from leading global manufacturers. In early 2022, Sapphire Bioscience was acquired by Bio-Techne, a major global developer of life science tools, to enhance its direct sales and support capabilities in the Oceania region. Beyond product distribution, the company is recognized for its technical expertise and commitment to supporting local researchers through various grants and awards. It operates as a key link between international biotechnology innovators and regional academic and clinical laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapphire Bioscience.